Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Brian H. Nathanson, Ph.D.
President & CEO
OptiStatim LLC
Poster(s):
(P-827) Epidemiology of Favorable vs. Unfavorable Outcomes in Hospitalized Patients with
S. aureus
Bacteremia in the US: A Multicenter Retrospective Cohort Study
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1537) Comparative effectiveness of early treatment with ceftolozane/tazobactam (C/T) relative to polymyxin (PB)-based therapy for non-COVID-19 patients (pts) with pneumonia (PNA) due to multi-drug resistant
Pseudomonas
aeruginosa
(MDR-PSA) across US Hospitals
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT